Methods for determining maternal health risks
The present description relates to a method for determining the risk of a pregnant woman developing a hypertensive disorder, more specifically gestational hyper-tension or late onset preeclampsia. The present description provides methods useful for determining risk that a pregnant individual will develop a hypertensive disorder or condition of pregnancy, such as gestational hypertension, early preeclampsia, late preeclampsia and related disorders. Several useful combinations of biochemical markers and related clinical population studies are described herein. Additionally, it is proposed herein that certain sets of biochemical markers can be used to determine risk of multiple hypertensive disorders in a single screen. The biochemical markers are PlGF, Activin A and optionally P-Selectin.
1. Method for determining the risk of late onset preeclampsia in a pregnant individual, comprising:
detecting the levels of biochemical markers placental growth factor (PlGF), Activin A and P-selectin in at least one blood sample from the pregnant individual; and
determining the increased risk of late onset preeclampsia if any of (i) to (iii) occur;
(i) when the level of PlGF in the blood sample obtained from the individual is decreased relative to the level of PlGF in a control sample,
(ii) when the level of Actin A in a sample obtained from the individual is increased relative to the level of Actin A in a control sample, and
(iii) when the level of P-selectin in a sample obtained from the individual is increased relative to the level of P-selectin in a control sample.
2. The method according to claim 1 , wherein sample is collected within first trimester.